Pacemaker study for heart amyloidosis
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This study tests if setting a pacemaker to a faster heart rate (70 beats per minute) can help people with a specific type of heart disease called ATTR cardiac amyloidosis. It is for people who already have a pacemaker and have heart failure symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with ATTR cardiac amyloidosis (a buildup of abnormal protein in the heart).
- You have a pacemaker and it is set to pace your heart at least 80% of the time.
- Your current pacemaker lower rate is set to 60 beats per minute.
- You have heart failure symptoms that limit your activity (NYHA class II or III).
- You are on a stable heart medication or not able to take standard therapies for ATTR amyloidosis.
- You are 18 years or older and can provide consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether pacing your heart at a faster rate helps people with cardiac amyloidosis (a condition where abnormal protein builds up in the heart). If you have a pacemaker and cardiac amyloidosis, this research might help doctors understand the best pacing settings for you.
This study tests if a pacemaker or defibrillator can spot a rare heart condition called cardiac amyloidosis by measuring electrical signals in the right ventricle. It might help people with thickened heart walls find out sooner if they have this treatable disease.
This trial tests if a pacemaker plus an ablation procedure can improve heart failure symptoms in people with atrial fibrillation. It is for those with moderate to severe heart failure who are already on the right medications.
This trial compares two types of pacemaker placement to improve heart function in people with heart failure. One method paces the heart's natural conduction system, while the other paces the lower chambers of the heart. The goal is to find which approach works better for heart resynchronization therapy.
This study tests whether taking a small tissue sample from the right side of the heart during a routine pacemaker or defibrillator procedure can help find a condition called cardiac amyloidosis, which causes stiffening of the heart muscle. It aims to improve early detection in people who already need a cardiac device and may have early signs of the disease.
This study tests whether adjusting the pacing rate on a special pacemaker (CRT or conduction system pacing) can improve heart function and daily symptoms in people with atrial fibrillation and heart failure.
Hear when a new Cardiac Amyloidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.